Prioritizing systemic therapies for genitourinary malignancies: Canadian recommendations during the COVID-19 pandemic

Authors

  • Aly-Khan A. Lalani
  • Kim N. Chi
  • Daniel Y.C. Heng
  • Christian K. Kollmannsberger
  • Srikala S. Sridhar
  • Normand Blais
  • Christina Canil
  • Piotr Czaykowski
  • Sebastien J. Hotte
  • Nayyer Iqbal
  • Denis Soulières
  • Dominick Bossé
  • Nimira S. Alimohamed
  • Naveen S. Basappa
  • Som D. Mukherjee
  • Eric Winquist
  • Lori A. Wood
  • Scott A. North

DOI:

https://doi.org/10.5489/cuaj.6595

Keywords:

systemic therapies, genitourinary malignancies, COVID-19, pandemic, Prioritizing

Downloads

Download data is not yet available.

Published

2020-04-05

How to Cite

Lalani, A.-K. A. ., Chi, K. N. ., Heng, D. Y. ., Kollmannsberger, C. K. ., Sridhar, S. S. ., Blais, N. ., Canil, C. ., Czaykowski, P. ., Hotte, S. J. ., Iqbal, N. ., Soulières, D. ., Bossé, D. ., Alimohamed, N. S. ., Basappa, N. S. ., Mukherjee, S. D. ., Winquist, E. ., Wood, L. A. ., & North, S. A. . (2020). Prioritizing systemic therapies for genitourinary malignancies: Canadian recommendations during the COVID-19 pandemic. Canadian Urological Association Journal, 14(5). https://doi.org/10.5489/cuaj.6595

Issue

Section

Rapid Communication